Tioga Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Tioga Pharmaceuticals has been formed to develop asimadoline, to treat pain in patients with irritable bowel syndrome and other gastrointestinal diseases. But unlike in-licensers that seek many shots on goal to balance risk, it is singularly focused on development of this asset.